Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRF vs PRP for Carpal Tunnel Syndrome
NCT05053477Phase 1Unknown
- Sponsor
- Alexandria University
- Start
- Sep 2018
- Primary completion
- Nov 2022
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of platelet-rich plasma in carpal tunnel syndrome (CTS) (3 arms), sponsored by Alexandria University. Primary endpoint: Visual Analogue Scale at 4 months. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT05053477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05053477.